SCHEMBL6000636

SCHEMBL6000636

CN(Cc1ccc(-c2csc(CNCc3ccc(C(=O)O)cc3)n2)cc1)c1ccc(C2CCCCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
MRE11 P49959 1/20 0.38
TRPA1 O75762 1/20 0.38
KDM4E B2RXH2 5/20 0.36
RAB9A P51151 4/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
S1PR1 P21453 1/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
STAT3 P40763 4/20 0.36
STAT1 P42224 1/20 0.36
STAT5B P51692 1/20 0.36
ALDH1A1 P00352 2/20 0.35
GCGR P47871 3/20 0.35
GIPR P48546 2/20 0.35
TRPM8 Q7Z2W7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001059 0.91 RXRA (0.42) RXRARXRBRXRGMRE11TRPA1
SCHEMBL6000640 0.90 MRE11 (0.44) MRE11TRPA1KDM4ERAB9APOLB
SCHEMBL5999733 0.89 RXRA (0.42) RXRARXRBRXRGMRE11TRPA1
SCHEMBL5999743 0.88 OPRM1 (0.46) POLBSTAT3STAT1STAT5BALDH1A1
SCHEMBL6001095 0.88 MRE11 (0.37) MRE11TRPA1S1PR1STAT3STAT1
SCHEMBL5585422 0.87 MAPT (0.44) RXRARXRBRXRGMRE11TRPA1
SCHEMBL5999889 0.87 RXRA (0.39) RXRARXRBRXRGMRE11TRPA1
SCHEMBL5585392 0.86 RXRA (0.42) RXRARXRBRXRGMRE11KDM4E
SCHEMBL6000638 0.86 RXRA (0.42) RXRARXRBRXRGMRE11KDM4E
SCHEMBL6000063 0.85 MRE11 (0.40) MRE11TRPA1RAB9AS1PR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 RXRA 867/4885RXRB 404/4885RXRG 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.